Common anti-COVID-19 drugs and their anticipated interaction with anesthetic agents

Common anti-COVID-19 drugs and their anticipated interaction with anesthetic agents

The corona virus disease 2019 (COVID-19) pandemic has till date (26/7/20) affected 1crore 62 lac 73 thousand 638 people globally with almost 6.5 lakh mortalities. COVID-19 has invaded the operation theatre and intensive care unit (ICU) in a short span of 6 months. It appears inevitable that all of u...

Full description

Bibliographic Details
Main Authors:	Shagun B Shah, Uma Hariharan, Rajiv Chawla
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2021-01-01
Series:	Journal of Anaesthesiology Clinical Pharmacology
Subjects:	anesthetic drugs azithromycin covid-19 dexamethasone favipiravir hydroxychloroquine ivermectin nitazoxanide remdesivir ritonavir tocilizumab
Online Access:	http://www.joacp.org/article.asp?issn=0970-9185;year=2021;volume=37;issue=2;spage=160;epage=170;aulast=Shah

Similar Items

Perspective: repurposed Drugs for COVID-19
by: Kesara Na-Bangchang, et al.
Published: (2022-08-01)

A narrative review of antiviral drugs used for COVID-19 pharmacotherapy
by: Subodh Kumar, et al.
Published: (2021-01-01)

Investigational medications in 9,638 hospitalized patients with severe COVID-19: lessons from the “fail-and-learn” strategy during the first two waves of the pandemic in 2020
by: Adam C. Delgado, et al.
Published: (2023-04-01)

Battling COVID-19: using old weapons for a new enemy
by: Rohit Kumar, et al.
Published: (2020-05-01)

COVID-19 possible medical treatments
by: Marzieh Mohammadi, et al.
Published: (2021-01-01)

COVID-19 treatment in children: A systematic review and meta-analysis
by: Prateek Kumar Panda, et al.
Published: (2021-01-01)

Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review
by: Shahamah Jomah, et al.
Published: (2020-09-01)

Therapeutic Strategies in the Management of COVID-19
by: Rajashri R. Naik, et al.
Published: (2021-02-01)

A randomized controlled trial of combined ivermectin and zinc sulfate versus combined hydroxychloroquine, darunavir/ritonavir, and zinc sulfate among adult patients with asymptomatic or mild coronavirus-19 infection
by: Sireethorn Nimitvilai, et al.
Published: (2022-01-01)

Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications
by: Abubakar AR, et al.
Published: (2020-12-01)

Familiar fixes for a modern malady: a discussion on the possible cures of COVID-19
by: Amrit Krishna Mitra
Published: (2020-12-01)

Clinical evaluation of selected Pharmacological Treatments used for Coronavirus (COVID-19) pandemic
by: hasan mohammed altemimy
Published: (2020-06-01)

Comparison of effectiveness of various treatment strategies in COVID-19 patients: A Systematic Review
by: Muhammad Shehryar Hussain, et al.
Published: (2020-08-01)

Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021
by: Safaet Alam, et al.
Published: (2021-06-01)

COVID-19: An Update about the Discovery Clinical Trial
by: Jean Jacques Vanden Eynde
Published: (2020-05-01)

COVID-19: A Brief Overview of the Discovery Clinical Trial
by: Jean Jacques Vanden Eynde
Published: (2020-04-01)

A Mini Review : Clinically Significant Potential Drug-Drug Interactions In COVID-19 and Comorbid Therapy
by: Ana Khusnul Faizah, et al.
Published: (2020-07-01)

Safety of Hydroxychloroquine, Favipiravir, and the Combination of Lopinavir and Ritonavir in the Treatment of the “First Wave” of the New Coronavirus Infection COVID-19
by: B. K. Romanov
Published: (2020-09-01)

Bronchopleural fistula development in the setting of novel therapies for acute respiratory distress syndrome in SARS-CoV-2 pneumonia
by: Daniel A. Placik, MD, et al.
Published: (2020-11-01)

Comparisons of treatment protocols for SARS-COV-2 in early pandemic: Single center experience ın Turkey
by: Tuncer Şimşek, et al.
Published: (2022-03-01)

Environmental and ecotoxicological effects of drugs used for the treatment of COVID 19
by: Donal Efrain Merma Chacca, et al.
Published: (2022-08-01)

A Comparative Study of Approved Drugs for SARS-CoV-2 by Molecular Docking
by: Achal Mishra, et al.
Published: (2021-06-01)

Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19)
by: Abhi Bhadra, et al.
Published: (2020-05-01)

Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review
by: Qomara WF, et al.
Published: (2021-11-01)

Repurposed pharmacological agents for the potential treatment of COVID-19: a literature review
by: Alina Kröker, et al.
Published: (2021-11-01)

Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities
by: Milo Gatti, et al.
Published: (2021-02-01)

Characteristics and outcomes of acute respiratory distress syndrome related to COVID-19 in Belgian and French intensive care units according to antiviral strategies: the COVADIS multicentre observational study
by: David Grimaldi, et al.
Published: (2020-10-01)

Covid-19: Effects of Azithromycin/Hydroxychloroquine/Ivermectin in ambulatory and hospitalized patients
by: Henry Mejia-Zambrano, et al.
Published: (2021-10-01)

SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches—Insights into Chemical Structure—Biological Activity and Toxicological Screening
by: Cristina Adriana Dehelean, et al.
Published: (2020-07-01)

Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations
by: Stanković Biljana, et al.
Published: (2020-01-01)

Case Report: Severe Diarrhea Caused by Cryptosporidium Diagnosed by Metagenome Next-Generation Sequencing in Blood
by: Shan H, et al.
Published: (2023-09-01)

A learning health system approach to the COVID‐19 pandemic: System‐wide changes in clinical practice and 30‐day mortality among hospitalized patients
by: Erin K. McCreary, et al.
Published: (2022-07-01)

Adjusted green spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form and spiked human plasma sample using different chemometric supported models
by: Mohamed S. Imam, et al.
Published: (2023-07-01)

Perbandingan Angka Kematian Terapi Antiviral Favipiravir dan Remdesivir pada Pasien COVID-19 Di RSUP Dr. Sardjito Yogyakarta
by: Nova Satriyani, et al.
Published: (2023-01-01)

Mucocutaneous adverse effects of remdesivir and favipiravir in patients with Covid-19 infection: A systematic review
by: Pradeep Balasubramanian, et al.
Published: (2022-01-01)

Treatment Options for COVID-19: A Review
by: Mukarram Jamat Ali, et al.
Published: (2020-07-01)

Association between self-reported evidence-based medicine competencies and prescribing of drugs without scientific evidence against mild COVID-19 among recently graduated physicians in Peru
by: Daniel Fernandez-Guzman, et al.
Published: (2023-04-01)

An early assessment of the efficacy of medicines in the treatment of patients with COVID-19
by: A. S. Kolbin
Published: (2020-05-01)

The Clinical Efficacy and Safety of Anti-Viral Agents for Non-Hospitalized Patients with COVID-19: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
by: Chih-Cheng Lai, et al.
Published: (2022-08-01)

A Journey From SARS-CoV-2 to COVID-19 and Beyond: A Comprehensive Insight of Epidemiology, Diagnosis, Pathogenesis, and Overview of the Progress into Its Therapeutic Management
by: Muhammad Harris Shoaib, et al.
Published: (2021-02-01)